Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 10 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
ARAF | ENSG00000078061 | 0.00 | 0.00 | 0 | 0 |
EDN1 | ENSG00000078401 | 0.00 | 0.00 | 0 | 0 |
FGF20 | ENSG00000078579 | 0.00 | 0.00 | 0 | 0 |
P2RY10 | ENSG00000078589 | 0.00 | 0.00 | 0 | 0 |
PKD2L2 | ENSG00000078795 | 0.00 | 0.00 | 0 | 0 |
BPIFB2 | ENSG00000078898 | 0.00 | 0.00 | 0 | 0 |
LXN | ENSG00000079257 | 0.00 | 0.00 | 0 | 0 |
LIPE | ENSG00000079435 | 0.00 | 0.28 | 0 | 1 |
AFM | ENSG00000079557 | 0.00 | 0.00 | 0 | 0 |
MOXD1 | ENSG00000079931 | 0.00 | 0.12 | 0 | 1 |
DCT | ENSG00000080166 | 0.00 | 0.00 | 0 | 0 |
SLC35C2 | ENSG00000080189 | 0.13 | 0.00 | 1 | 0 |
EPHA6 | ENSG00000080224 | 0.00 | 0.00 | 0 | 0 |
SCTR | ENSG00000080293 | 0.00 | 0.00 | 0 | 0 |
KCNN2 | ENSG00000080709 | 0.00 | 0.00 | 0 | 0 |
MOK | ENSG00000080823 | 0.17 | 0.00 | 1 | 0 |
CXCL2 | ENSG00000081041 | 0.00 | 0.00 | 0 | 0 |
AFP | ENSG00000081051 | 0.00 | 0.00 | 0 | 0 |
COL4A4 | ENSG00000081052 | 0.00 | 0.19 | 0 | 1 |
SLC13A1 | ENSG00000081800 | 0.00 | 0.00 | 0 | 0 |
Showing page 10 |
first page | previous page | next page | last page |